Expertise and resources to facilitate
Read or watch to learn more
Preclinical characterization of oncology nanomedicines
Expediting nanomedicine development

Nanotechnology Characterization Lab

Eliminating suffering and death from cancer requires an unprecedented collaborative effort that leverages resources from government, industry, and academia. Working in concert with the National Institute of Standards and Technology (NIST) and the U.S. Food and Drug Administration (FDA), the National Cancer Institute (NCI) established the Nanotechnology Characterization Laboratory to perform preclinical efficacy and toxicity testing of nanoparticles.

The NCL serves as a national resource and knowledge base for all cancer researchers to facilitate the regulatory review of nanotechnologies intended for cancer therapies and diagnostics. By providing the critical infrastructure and characterization services to nanomaterial providers, the NCL accelerates the transition of basic nanoscale particles and devices into clinical applications, thereby reducing suffering and death from cancer.

There are multiple ways the NCL can help nanotech researchers and developers advance their technology, including characterization, reformulation, optimization, lead selection, method development, and more.

Learn about how to collaborate with the NCL.

News & Updates

Investigators at the NCL have developed a drug delivery platform that targets scavenger receptor A1, a receptor highly expressed in macrophages, monocytes, mast cells, and...

Beginning in 2019 the NCL will accept applications twice per year, a change from previous years in which applications were accepted quarterly.

Each quarter the NCL accepts the most promising cancer nanomedicine candidates into its Assay Cascade characterization and testing program.

Meet Us @

The RNA Nanotechnology Gordon Research Conference (GRC) will be held in Ventura, CA, January 13-18, 2019.

The 58th annual meeting of the Society of Toxicology (SOT) will be held in Baltimore, MD, March 10-14. NCL will be sending two scientists to this year’s event, Dr....